Apolipoprotein A5 and Hypertriglyceridemia (Editorials)
Clinical Chemistry, 2005, Feb, 51, 2
-
- CHF 3.00
-
- CHF 3.00
Publisher Description
Hypertriglyceridemia is associated with increased risk of coronary heart disease (CHD) (1-5), and it is an integral component of the overlapping syndromes of familial combined hyperlipidemia, insulin resistance syndrome, atherogenic lipoprotein profile, and hyperapobetali-poproteinemia (6). More than one mechanism may be involved in the increased risk of CHD associated with increased serum triglycerides: * Triglyceride-rich lipoproteins (TGRLs) may participate directly in atherogenesis, particularly when they have undergone attack by oxygen free radicals (7).
More Books by Clinical Chemistry
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report)
2009
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005